According to Oxford University Press Release Dexamethasone could cut down death rates significantly in critically ill COVID-19 patients .
The British government authorized the use of dexamethasone for COVID-19 patients
The Indian health ministry guidelines recently included the use of dexamethasone as an alternate treatment option for some COVID-19 patients showing certain specific signs of worsening status
Govt considering hike in API import duties.. Positive for Indian Pharma
The government is considering increasing the import duty on active pharmaceutical ingredients (APIs) to 20-25% from the current 10%, to help boost local manufacturing of the bulk drugs.
Niacinamide concentrations can be helpful in lightening dark spots.
The growth trajectory for the Indian pharmaceutical industry is likely to remain at 10-13 per cent in 2020-21 despite challenges, according to rating agency Icra.
